Patent details

Basic Information

Publication number:

EP2397122

PCT Application Number:

Type:

European Patent Granted for LU

Legal Status:

Lapsed

Application number:

EP111796371

PCT Publication Number:

First applicant's nationality:

Translation Language:

EPO Publication Language:

English

English Title of Invention:

Formulations of neramexane dosage forms

French Title of Invention:

Formulations de formes pharmaceutiques de néramexane

German Title of Invention:

Formulierungen aus Neramexan-Dosierformen

SPC Number:

Dates

Filing date:

16/06/2005

Grant date:

14/05/2014

EP Publication Date:

14/05/2014

PCT Publication Date:

Claims Translation Received Date:

Translations Received Date (B1 EP Publication):

Translations Received Date (B2 EP Publication):

Translations Received Date (B3 EP Publication):

Publication date:

21/12/2011

EP B1 Publication Date:

14/05/2014

EP B2 Publication Date:

EP B3 Publication Date:

Lapsed date:

16/06/2014

Expiration date:

16/06/2025

Renunciation date:

Revocation date:

Annulment date:

Owner

From:

16/06/2005

 

 

Name:

Merz Pharma GmbH & Co. KGaA

Address:

Eckenheimer Landstrasse 100, 60318 Frankfurt, Germany (DE)

Inventor

1

Name:

Yang Yan

Address:

United States (US)

2

Name:

Rao Niranjan

Address:

United States (US)

3

Name:

Dedhiya Mahendra G.

Address:

United States (US)

4

Name:

Periclou Antonia

Address:

United States (US)

5

Name:

Abramowitz Wattanporn

Address:

United States (US)

6

Name:

Janjikhel Rajiv

Address:

United States (US)

7

Name:

Seiller Erhard

Address:

Germany (DE)

8

Name:

Hauptmeier Bernhard

Address:

Germany (DE)

Priority

Priority Number:

581244 P

Priority Date:

17/06/2004

Priority Country:

United States (US)

Classification

Main IPC Class:

A61K 9/20;

Filing date	Document type	Number of pages